PTC Therapeutics, Inc. (PTCT)

SEC filing

PTC Therapeutics, Inc.

PTCT · CIK 1070081

4 · Oct 13, 2026 · EXEC. VP AND CLO Boulding Mark Elliott sold 192 shares at $64.26/share ($12,338); exercised options for 384 shares

EXEC. VP AND CLO Boulding Mark Elliott sold 192 shares at $64.26/share ($12,338); exercised options for 384 shares

xslF345X06/form4-10132026_051001.xml

xslF345X06/form4-10132026_051001.xmlSEC.gov

Graphics and non-inline formats (not embedded below).